©2008 The WJG Press and Baishideng.
World J Gastroenterol. Oct 21, 2008; 14(39): 6065-6071
Published online Oct 21, 2008. doi: 10.3748/wjg.14.6065
Published online Oct 21, 2008. doi: 10.3748/wjg.14.6065
Table 1 Details of prescriptions of the two clarithromycin products
| Clarithromycin | ||
| Sustained-release | Immediate release | |
| Total number of prescriptions | 949 | 197 |
| Number of prescriptions for alimentary disease | 164 | 110 |
| Mean age (range) yr | 45.9 (18-82) | |
| Male:Female | 137:137 | |
| Number of prescriptions for anti-H pylori therapy | 159 | 96 |
| Triple therapy | 151 | 83 |
| PPI/Clarithromycin/Amoxicillin | 43 | 58 |
| PPI/Clarithromycin/Furazolidone | 44 | 21 |
| PPI/Clarithromycin/Levofloxacin | 63 | 1 |
| PPI/Clarithromycin/Metronidazole | 1 | 1 |
| PPI/Clarithromycin/Tinidazole | 0 | 2 |
| Quadruple therapy | 5 | 6 |
| PPI/Bismuth/Amoxicillin/Clarithromycin | 0 | 2 |
| PPI/Bismuth/ Furazolidone/Clarithromycin | 1 | 3 |
| PPI/Bismuth/Levofloxacin/Clarithromycin | 4 | 1 |
| Dual therapy | 3 | 7 |
| Clarithromycin/PPI | 2 | 7 |
| Clarithromycin/Ranitidine bismuth citrate | 1 | 0 |
- Citation: Zhou Q, Zhu LL, Yan XF, Pan WS, Zeng S. Drug utilization of clarithromycin for gastrointestinal disease treatment. World J Gastroenterol 2008; 14(39): 6065-6071
- URL: https://www.wjgnet.com/1007-9327/full/v14/i39/6065.htm
- DOI: https://dx.doi.org/10.3748/wjg.14.6065